Generate Biomedicines, Inc.
GENB
$13.19
$0.413.21%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 516.64M | 393.63M | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 18.75M | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 535.39M | -- | |||
|
|
|||||
| Total Current Assets | 535.39M | -- | |||
| Net Property, Plant & Equipment | 85.60M | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 4.75M | -- | |||
| Total Assets | 625.74M | -- | |||
|
|
|||||
| Total Accounts Payable | 7.52M | -- | |||
| Total Accrued Expenses | 16.95M | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 14.26M | -- | |||
| Total Finance Division Other Current Liabilities | 19.66M | -- | |||
| Total Other Current Liabilities | 19.66M | -- | |||
| Total Current Liabilities | 58.39M | -- | |||
|
|
|||||
| Total Current Liabilities | 58.39M | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 51.31M | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 1.24M | -- | |||
| Total Liabilities | 110.94M | -- | |||
|
|
|||||
| Common Stock & APIC | 1.25B | -- | |||
| Retained Earnings | -737.74M | -- | |||
| Treasury Stock & Other | 24.00K | -- | |||
| Total Common Equity | 514.80M | -434.52M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | 790.95M | |||
|
|
|||||
| Total Common Equity | 514.80M | -434.52M | |||
| Total Preferred Equity | -- | 790.95M | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 514.80M | 355.86M | |||
|
|
|||||